Clinical Trials Logo

Congenital Heart Disease clinical trials

View clinical trials related to Congenital Heart Disease.

Filter by:

NCT ID: NCT03360370 Completed - Clinical trials for Congenital Heart Disease

Neurodevelopmental Disorders in Children With Congenital Heart Disease

NeuroDis-CHD
Start date: December 6, 2017
Phase:
Study type: Observational

Children with congenital heart disease are at risk for neurodevelopmental disorders, these disorders impacting their quality of life and their integration into society. The aim of this study is to detect neurodevelopmental disorders in children (aged from 6 to 66 months) with congenital heart disease in Nord-Pas-De-Calais (France) and to evaluate the frequency and risk factors of these neurodevelopmental disorders for a better follow-up. This study will help implementing a specific program for the evaluation and management of neurodevelopmental disorders in children suffering from congenital heart disease in Nord-Pas-De-Calais and more globally, in the region Hauts-De-France.

NCT ID: NCT03347214 Completed - Clinical trials for Congenital Heart Disease

dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC)

Start date: October 20, 2017
Phase:
Study type: Observational

Background: Researchers do not know much about the causes of congenital heart disease (CHD). They do know that many factors play a role. Some factors are environmental. Some are genetic. But few specific factors have been identified. And researchers do not know how many involve genes. They want to study data that has already been collected from people with CHD and their families. Objectives: To identify genetic variations related to CHD. To study molecules related to vascular disease in order to learn new ways to treat it. Eligibility: People who already participated in the Pediatric Cardiac Genomics Consortium (PCGC) study Design: Researchers will study data that was already collected in the PCGC. There will be no active participants. Researchers will get access to the data through the coordinating center. They will not download data to local storage devices. The data will have no personally identifying information....

NCT ID: NCT03316508 Completed - Clinical trials for Congenital Heart Disease

Copeptin- Relevance as a Perioperative Marker in Pediatric Cardiac Surgery

Start date: June 14, 2017
Phase:
Study type: Observational

This study evaluates the relevance of Copeptin in children with congenital heart disease undergoing cardiac surgery with the need of cardiopulmonary bypass. Three blood samples are taken of each patient. The first and second sample are collected in the operation room before and after the procedure and the third sample on the first postoperative day at the intensive care unit.

NCT ID: NCT03297918 Completed - Heart Failure Clinical Trials

Impact of a Structural Phonation Training on Respiratory Muscle Function in Patients With Structural Heart Disease

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

Most patients with complex congenital heart disease and cardiomyopathy from acquired heart disease have reduced exercise capacity. Exercise capacity is associated with respiratory muscle strength and function. If structured respiratory muscle training positively influences respiratory muscle function in patients with structural heart disease is not well known. The aim of this study is to investigate whether regular singing lessons and breathing exercises improve respiratory muscle strength in patients with congenital or acquired structural heart disease.

NCT ID: NCT03255850 Completed - Clinical trials for Congenital Heart Disease

The Impact of Congenital Heart Disease on the Psychological Well Being and Quality of Life in the Hong Kong Chinese Adolescents

Start date: August 15, 2017
Phase:
Study type: Observational

This study aims to examine the psychological well-being and QoL of Hong Kong Chinese adolescents with CHD by - comparing the self-esteem level, depressive symptoms, and quality of life of adolescents suffering from CHD with healthy norms and cancer survivors. - identifying possible factors affecting the quality of life of adolescents suffering from CHD.

NCT ID: NCT03248830 Completed - Clinical trials for Congenital Heart Disease

Non-invasive Hemoglobin Monitoring in Congenital Heart Diseased Children

Start date: February 20, 2018
Phase:
Study type: Observational

The investigators will evaluate the accuracy of non-invasive hemoglobin monitor (Sp-Hb) compared to traditional laboratory hemoglobin (Lab-Hb) in children with congenital heart disease. The investigators will also compare the accuracy of Sp-Hb in cyanotic children to acyanotic children.

NCT ID: NCT03214120 Completed - Clinical trials for Congenital Heart Disease

Does Modified Ultrafiltration Affect Thromboelastography Results?

Start date: January 8, 2018
Phase:
Study type: Observational [Patient Registry]

The study is to evaluate the effect of modified ultrafiltration on different components of Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary bypass.

NCT ID: NCT03170778 Completed - Clinical trials for Congenital Heart Disease

Ocular and Vision Problems in Patients After Fontan Operation

Start date: February 13, 2016
Phase:
Study type: Observational

The purposes of this study are to identify indicators of vision problems and ocular abnormalities in patients with a Fontan circulation through a standardized questionnaire and to correlate the intraocular pressure measured with the Icare tonometer with central venous pressure measured with the VENUS 2000 CVP non-invasive system to determine whether intraocular pressure can be used as a surrogate measure of increased central venous pressure in patients with a Fontan circulation.

NCT ID: NCT03170024 Completed - Clinical trials for Congenital Heart Disease

Health Literacy in Adults With Congenital Heart Disease

Start date: October 31, 2015
Phase:
Study type: Observational

Currently, both oral and written health education make certain assumptions about the health literacy of patients and their parents. The prevalence of health literacy issues is unknown in the adult congenital heart disease (CHD) population. Having a better understanding of a patient's and/or their parents' health literacy will help us develop appropriate education and teaching tools to meet the patient's and their parents' needs.

NCT ID: NCT03154476 Completed - Cirrhosis Clinical Trials

Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study

SiFALD
Start date: July 5, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the medication, sildenafil (also known as Revatio), can slow or stop the progression of liver disease in patients who previously had a Fontan operation.